Hydrochloric Acid → HCID 10346890, compound

HRID 2184098Notes

Reaction equation

HRID 2184098 reaction equation
Cl.[Cl:2][C:3]1[CH:8]=[CH:7][C:6]([CH:9]2[CH:14]=[CH:13][NH:12][CH2:11][CH2:10]2)=[CH:5][CH:4]=1.C(N(C(C)C)C(C)C)C.[C:24]1([C:30]2([C:43]3[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=3)[O:34][C:33]3[CH:35]=[CH:36][C:37]([S:39](Cl)(=[O:41])=[O:40])=[CH:38][C:32]=3[O:31]2)[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1.Cl>C(Cl)Cl>[Cl:2][C:3]1[CH:8]=[CH:7][C:6]([C:9]2[CH2:14][CH2:13][N:12]([S:39]([C:37]3[CH:36]=[CH:35][C:33]4[O:34][C:30]([C:24]5[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=5)([C:43]5[CH:44]=[CH:45][CH:46]=[CH:47][CH:48]=5)[O:31][C:32]=4[CH:38]=3)(=[O:40])=[O:41])[CH2:11][CH:10]=2)=[CH:5][CH:4]=1

Participants

6

Procedure

4-(4-Chlorophenyl)-1,2,3,4-tetrahydropyridine hydrochloride (19.37 mg, 0.10 mmol) was suspended in methylene chloride (2 ml). Ethyldiisopropylamine (0.035 ml, 0.20 mmol) was added and the solution was shaken for 10 minutes at room temperature. 2,2-Diphenyl-benzo[1,3]dioxole-5-sulfonyl chloride (37.28 mg, 0.10 mmol) was added and the reaction was shaken at room temperature for 12 hours. Aqueous HCl (0.1 N, 1.0 ml) was added and the mixture shaken for 30 minutes, the aqueous layer removed and the organic phase concentrated and purified by preparative reverse phase HPLC (YMC, ODS-AQ packing; 20%→95% CH3CN/H2O) to yield the sulfonamide (2.6 mg, 5%).

Workup

  1. stirringthe reaction was shaken at room temperature for 12 hours
  2. stirringthe mixture shaken for 30 minutes
  3. customthe aqueous layer removed
  4. concentrationthe organic phase concentrated
  5. custompurified by preparative reverse phase HPLC (YMC, ODS-AQ packing; 20%→95% CH3CN/H2O)

Sources & evidence

ORD record
ord-6cc40c0522784c2fb5d83771b105e9d7
Source dataset
uspto-grants-2005_05
Patent number
US06900227B2

Reaction notes

Loading…